6192-01-4

Basic information

• Product Name: 3-ETHOXYACRYLIC ACID
• Synonyms: (2E)-3-ETHOXYACRYLIC ACID;3-ETHOXYACRYLIC ACID;RARECHEM AL BO 0253;3-Ethyoxyacrylic acid;3-ethoxyprop-2-enoic acid;2-Propenoic acid, 3-ethoxy-;(E)-3-ethoxyacrylic acid
• CAS NO: 6192-01-4
• Molecular Formula: C₅H₈O₃
• Molecular Weight: 116.12
• Product Categories: Small molecule;Aliphatics;Carboxylic Acids;Carboxylic Acids
• Mol File: 6192-01-4.mol

Chemical Properties

• Melting Point: 109 °C
• Boiling Point: 70-140 °C(Press: 1 Torr)
• Appearance: /
• Density: 1.1100 g/cm3
• Storage Temp.: 2-8°C
• PKA: 4.86±0.10(Predicted)
• CAS DataBase Reference: 3-ETHOXYACRYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-ETHOXYACRYLIC ACID(6192-01-4)
• EPA Substance Registry System: 3-ETHOXYACRYLIC ACID(6192-01-4)

Safety Data

• Hazard Codes: C,Xi
• Statements: 36
• Safety Statements: 26
• Hazardous Substances Data: 6192-01-4(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Synthesis, p. 1016, 1986 DOI: 10.1055/s-1986-31854

InChI:InChI=1/C5H8O3/c1-2-8-4-3-5(6)7/h3-4H,2H2,1H3,(H,6,7);

Upstream product

• 6191-99-7 (2E)-3-ethoxyprop-2-enoyl chloride 
• 5941-55-9 ethyl 3-ethoxyacrylate 
• 64-17-5 ethanol 
• 54299-82-0 C₉H₁₇NO₂ 
• 19483-24-0 cis-β-Ethoxyacrylsaeure 
• 59938-06-6 (E)-4-Ethoxy-1,1,1-trifluoro-3-buten-2-one 
• 59938-07-7 (3E)-1,1,1-trichloro-4-ethoxybut-3-en-2-one 
• 16339-88-1 (E)-1-bromo-2-ethoxyethene 
• 124-38-9 carbon dioxide 
• 75-99-0 2,2-Dichloropropionic acid 
• 594-48-9 2,2-dibromopropionic acid 
• 105-36-2 ethyl bromoacetate 
• 122-51-0 orthoformic acid triethyl ester 
• 1001-26-9 ethyl 3-ethoxyacrylate 

Downstream Products

• 773138-32-2 2-hydroxy-benzene-1,3,5-tricarboxylic acid triethyl ester 
• 6191-99-7 (2E)-3-ethoxyprop-2-enoyl chloride 
• 923973-02-8 (E)-N-(1-(2,6-dichlorophenyl)-4-methyl-5-oxo-4,5-dihydro-1H-pyrazol-3-yl)-3-ethoxyacrylamide 
• 928627-14-9 trans-N-(3-bromo-2-methoxyphenyl)-3-ethoxy-2-propenamide 
• 115983-78-3 (E)-3-ethoxypropenoyl isocyanate 
• 6191-99-7 3-ethoxyacryloyl chloride 
• 1621424-10-9 benzyl (E)-3-ethoxyacrylate 
• 64-17-5 ethanol 
• 75-07-0 acetaldehyde 
• 15719-64-9 methylammonium carbonate 
• 103130-62-7 (2S)-2-phenylpentan-3-one 

Relevant articles and documents

New 8-Nitroquinolinone Derivative Displaying Submicromolar in Vitro Activities against Both Trypanosoma brucei and cruzi

An antikinetoplastid pharmacomodulation study was conducted at position 6 of the 8-nitroquinolin-2(1H)-one pharmacophore. Fifteen new derivatives were synthesized and evaluated in vitro against L. infantum, T. brucei brucei, and T. cruzi, in parallel with a cytotoxicity assay on the human HepG2 cell line. A potent and selective 6-bromo-substituted antitrypanosomal derivative 12 was revealed, presenting EC50 values of 12 and 500 nM on T. b. brucei trypomastigotes and T. cruzi amastigotes respectively, in comparison with four reference drugs (30 nM ≤ EC50 ≤ 13 μM). Moreover, compound 12 was not genotoxic in the comet assay and showed high in vitro microsomal stability (half life >40 min) as well as favorable pharmacokinetic behavior in the mouse after oral administration. Finally, molecule 12 (E° = -0.37 V/NHE) was shown to be bioactivated by type 1 nitroreductases, in both Leishmania and Trypanosoma, and appears to be a good candidate to search for novel antitrypanosomal lead compounds.

UDP GLYCOSYLTRANSFERASE INHIBITORS AND METHODS OF USE

Described herein is a compound of Formula (I), and pharmaceutically acceptable salts thereof. Also described herein are compositions and the use of such compositions in methods of treating a variety of diseases and conditions, in particular Krabbe's Disease (KD) and Metachromatic leukodystrophy (MLD).

INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE

Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').

INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE

The present disclosure is directed to compounds of formula I and methods of their use and preparation, as well as compositions comprising compounds of formula I.

Enantioselective Synthesis of N?H-Free 1,5-Benzothiazepines

An enantioselective sulfa-Michael-cyclization reaction was developed for the synthesis of 1,5-benzothiazepines with versatile pharmacological activities. The reaction between 2-aminothiophenol and α,β-unsaturated pyrazoleamides gave direct access to N?H-free 1,5-benzothiazepines in the presence of a chiral N,N′-dioxide/Yb(OTf)3complex. Excellent enantioselectivities (up to 96 % ee) and high yields (up to 99 %) were obtained for a broad range of substrates under mild reaction conditions. This method provided a facile approach to the antidepressant drug (R)-(?)-Thiazesim.

Novel heterocyclic antibacterial compounds

The invention provides heterocyclic organic compounds that inhibit bacterial DNA polymerase IIIC and type II bacterial topoisomerase. The invention further provides compounds that are useful as intermediates in the synthesis of such heterocyclic organic compounds. Syntheses and uses of such heterocyclic organic molecules are also described.

2-Ethoxyvinyllithiums and diethoxyvinyllithiums: What makes them stable or fragile?

The elusive (E)-2-ethoxyvinyllithium can be readily generated in tetrahydrofuran at -75 °C from (E)-1-bromo-2-ethoxyethylene by halogen/metal exchange and subsequently trapped with electrophiles. Alkylation opens a convenient entry to (E)-configurated enethers. (E)-2-Ethoxyvinyllithium decomposes rapidly at -50 °C whereas its (Z)-isomer, which lacks the possibility to eliminate lithium ethoxide in a favorable anti-periplanar process, is stable under the same conditions. (E)-1,2-Diethoxyvinyllithium even sustains reflux temperatures (approximately 75 °C). 2,2-Diethoxyvinyllithium and (Z)-1,2-diethoxyvinyllithium can be conserved at 0 °C although this time loss of alcoholate can occur in the anti-mode. Obviously it matters whether the energy-rich ethoxyacetylene is formed as the elimination product or simple acetylene, as in the case of (E)-2-ethoxyvinyllithium.

Haloacetylated Enol Ethers. 8 [12]. Reaction of β-Alkoxyvinyl Trihalomethyl Ketones with Guanidine Hydrochloride. Synthesis of 4-Trihalomethyl-2-Aminopyrimidines

In this work the results of the reaction of β-alkoxyvinyl trihalomethyl ketones 1, 2a-e, with guanidine hydrochloride are reported. Depending on the ketone 1 or 2 and the conditions under which the reactions were carried out, 4-trihalomethyl-2-amino pyrimidines, β-alkoxyvinyl carboxylic acids, or β-acetal carboxylic esters were obtained.

Synthesis of racemic carbocyclic cyclopropanoid nucleoside analogues

As further representatives of a novel class of carbocyclic nucleoside analogues (±)-cis- and (±)-trans-(2-hydroxymethylcyclopropyl)-uracil, -thymine, and -inosine were synthesized from the corresponding dialkyl 1,2-cyclopropane dicarboxylates.

Electroorganic Synthesis, 56. Synthesis of Advanced Prostaglandin Precursors by Kolbe Electrolysis, I. - Preparation of (1'R,4'S,3R/S)-3-(cis-4-Acetoxycyclopent-2-enyloxy)-3-ethoxypropionic Acid

The key intermediate of a novel synthesis of prostaglandin precursors, (1'R,4'S,3R/S)-3-(cis-4-acetoxycyclopent-2-enyloxy)-3-ethoxypropionic acid (3), is prepared by two different synthetic sequences: In a first strategy transacetalization of ethyl 3,3-diethoxypropionate (6) with (1R,4S)-4-acetoxy-1-hydroxy-2-cyclopentene (7) leads to the formation of the mixed acetal 8.By subsequent hydrolysis and acylation 8 could be converted into acid 3 in six steps in 6percent overall yield.However, the generation of acid 3 by bromoalkoxidation of 3-ethoxyacrylates 13d, e and subsequent electrochemical reduction proved to be more efficient.In this reduction it is possible to debrominate the α-bromo esters 14d, e and to remove the 2-haloethyl ester group in one step.Using this reaction sequence, we could synthesize acid 3 in five steps in 38percent overall yield. - Key Words: Kolbe electrolysis / Radical cyclization / Electrochemical dehalogenation / Prostaglandins